journal article·2018-09

Crystal structure of terazosin hydrochloride dihydrate (Hytrin ® ), C 19 H 26 N 5 O 4 Cl(H 2 O) 2

Austin M. Wheatley, James A. Kaduk, Martin Vickers, Amy M. Gindhart, Joseph G. Sunzeri, Thomas N. Blanton

Powder Diffraction· Volume 33· Issue 3
Publisher page

Abstract

The crystal structure of terazosin hydrochloride dihydrate has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional techniques. Terazosin hydrochloride dihydrate crystallizes in space group P- 1 (#2) with a = 10.01402(4), b = 10.89995(4), c = 11.85357(4) Å, α = 89.5030(3), β = 71.8503(3), γ = 66.5632(2)°, V = 1118.143(8) Å 3 , and Z = 2. The terazosin cation occurs in an extended conformation. The crystal structure is dominated by hydrogen bonds. The most notable are the O–H···Cl from the water molecules to the chloride anion and N–H···Cl from the protonated ring nitrogen to the chloride. The amino group donates protons to each of the two water molecules. The powder pattern has been submitted to ICDD ® for inclusion in the Powder Diffraction File™.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Polymer Synthesis and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. 10.1107/S010876819901508610.1107/S0108768199015086 ↗
2. Open Babel: an open chemical toolbox
3. Bravais · 1866
4. 10.1039/B818330A10.1039/B818330A ↗
5. 2016
6. 10.1107/S002188988708709010.1107/S0021889887087090 ↗
7. Meyer G. A. and Bauer J. F. (1994). “Terazosin polymorph and pharmaceutical composition,” US Patent 5,294,615.
8. 10.1063/1.46788210.1063/1.467882 ↗
9. Wavefunction, Inc. (2017). Spartan ‘16 Version 2.0.1, Wavefunction Inc., 18401 Von Karman Ave., Suite 370, Irvine CA 92612.
10. 10.1002/qua.2465810.1002/qua.24658 ↗
11. Wheatley A. M. and Kaduk J. A. (2018). “Crystal structures of ammonium citrates,” manuscript in preparation.10.1017/S0885715618000829 ↗
12. A new law of crystal morphology extending the law of Bravais
13. 10.1107/S010876810200347610.1107/S0108768102003476 ↗
14. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
15. Roteman R. (1979). “1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl) piperazine hydrochloride dihydrate,” US Patent 4,251,532.
16. 10.1063/1.296926010.1063/1.2969260 ↗
17. Cannata V. , Ferrario T. , and Galbiati B. (1999). “Process for the Production of the Form I of the Terazosin Monohydrochloride Anhydrous,” US Patent 5856482 (ALFA Chemicals Italiana S.R.L.).
18. 10.1007/BF0054909610.1007/BF00549096 ↗
19. 10.1107/S002188989400421810.1107/S0021889894004218 ↗
20. 10.1017/S088571561700028810.1017/S0885715617000288 ↗
21. Etudes sur la loi de Bravais
22. 10.1107/S205252061800233010.1107/S2052520618002330 ↗
23. 10.1021/ci049780b10.1021/ci049780b ↗
24. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
25. 10.1021/ar00172a00510.1021/ar00172a005 ↗
26. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
27. 10.1107/S090904950801843810.1107/S0909049508018438 ↗
28. Larson A. C. and Von Dreele R. B. (2004). General Structure Analysis System (GSAS) (Los Alamos National Laboratory Report LAUR 86-784).
29. 10.1107/S002188980706790810.1107/S0021889807067908 ↗
30. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
31. Wolff S. K. , Grimwood D. J. , McKinnon M. J. , Turner M. J. , Jayatilaka D. , and Spackman M. A. (2012). Crystal Explorer Version 3.1 (University of Western Australia).
32. 10.1107/S002188980201523610.1107/S0021889802015236 ↗
33. 10.1002/jcc.2315310.1002/jcc.23153 ↗
34. 10.1107/S010876810402030010.1107/S0108768104020300 ↗
35. 10.1107/S002188989800600110.1107/S0021889898006001 ↗
36. 10.1107/S002188980100224210.1107/S0021889801002242 ↗
37. 10.1002/anie.19951555110.1002/anie.199515551 ↗
38. Kabekkodu · 2017